Southeast Netherlands Advanced Metastatic Breast Cancer Registry
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
Recruiting · NCT03577197 · Registry updated 2024-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Southeast Netherlands Advanced Metastatic Breast Cancer Registry | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2024-07-23 | NCT03577197 |
10 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Academisch Ziekenhuis Maastricht | 8 |
| AstraZeneca | 806 |
| Daiichi Sankyo | 144 |
| Eisai Inc. | 40 |
| Eli Lilly and Company | 370 |
| Gilead Sciences | 180 |
| Novartis | 114 |
| Pfizer | 431 |
| Roche Pharma AG | 59 |
| ZonMw: The Netherlands Organisation for Health Research and Development | 103 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Multiple hospitals in the Netherlands (see Eligibility) | Maastricht | Netherlands | 1 |